Innovative Cellular Therapeutics Holdings Ltd sold LYEL
July 17, 2026 · Form 4 insider transaction
Innovative Cellular Therapeutics Holdings Ltd sold 10 shares of Lyell Immunopharma, Inc. at $13.70 per share, a transaction worth $137.00. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
10
Price
$13.70
Total value
$137.00
Role10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 17, 2026
Filing dateJuly 20, 2026
Shares owned after2,857,480
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects 2,857,490 shares of Common Stock beneficially owned by the Reporting Person immediately prior to the reported transaction, less the 10 shares sold.